This article has multiple issues. Please help improve it or discuss these issues on the talk page . (Learn how and when to remove these messages)
|
Abbreviation | TERMIS |
---|---|
Formation | 2005 |
Type | INGO 501(c)(3) [1] |
Purpose | medical research |
Region served | worldwide |
Official language | english |
President | Anthony S. Weiss |
Website | https://termis.org/ |
Tissue Engineering and Regenerative Medicine International Society is an international learned society dedicated to tissue engineering and regenerative medicine. [1]
Regenerative medicine involves processes of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function. A major technology of regenerative medicine is tissue engineering, [2] which has variously been defined as "an interdisciplinary field that applies the principles of engineering and the life sciences toward the development of biological substitutes that restore, maintain, or improve tissue function", or "the creation of new tissue by the deliberate and controlled stimulation of selected target cells through a systematic combination of molecular and mechanical signals". [3]
Tissue engineering emerged during the 1990s as a potentially powerful option for regenerating tissue and research initiatives were established in various cities in the US and in European countries including the UK, Italy, Germany and Switzerland, and also in Japan. Soon fledgling societies were formed in these countries in order to represent these new sciences, notably the European Tissue Engineering Society (ETES) and, in the US, the Tissue Engineering Society (TES), soon to become the Tissue Engineering Society international (TESi) and the Regenerative Medicine Society (RMS). [4]
Because of the overlap between the activities of these societies and the increasing globalization of science and medicine, considerations of a merger between TESI and ETES and RMS were initiated in 2004 and agreement was reached during 2005 about the formation of the consolidated society, the Tissue Engineering and Regenerative Medicine International Society (TERMIS). [5] Election of officers for TERMIS took place in September 2005, and the by-laws were approved by the Board.
Rapid progress in the organization of TERMIS took place during late 2005 and 2006. The SYIS, Student and Young Investigator Section was established in January 2006, website and newsletter launched and membership dues procedures put in place.
It was determined that each Chapter would have its own Council, the overall activities being determined by the Governing Board, on which each Council was represented, and an executive committee.
At the beginning of the Society, it was agreed that there would be Continental Chapters of TERMIS, initially TERMIS-North America (TERMIS-NA) and TERMIS-Europe (TERMIS-EU), to be joined at the time of the major Shanghai conference in October 2005 by TERMIS-Asia Pacific (TERMIS-AP). It was subsequently agreed that the remit of TERMIS-North America should be expanded to incorporate activity in South America, the chapter becoming TERMIS-Americas (TERMS-AM) officially in 2012.
The Student and Young Investigator Section of TERMIS (TERMIS-SYIS) brings together undergraduate and graduate students, post-doctoral researchers and young investigators in industry and academia related to tissue engineering and regenerative medicine. [6] It follows the organizational and working pattern of TERMIS.
Language | English |
---|---|
Publication details | |
Publisher | Mary Ann Liebert on behalf of the Tissue Engineering and Regenerative Medicine International Society |
Standard abbreviations | |
ISO 4 | Tissue Eng. |
Indexing | |
Tissue Engineering | |
ISSN | 1076-3279 (print) 1557-8690 (web) |
Tissue Engineering Part A | |
ISSN | 1937-3341 (print) 1937-335X (web) |
Tissue Engineering Part B: Reviews | |
ISSN | 1937-3368 (print) 1937-3376 (web) |
Tissue Engineering Part C: Methods | |
ISSN | 1937-3384 (print) 1937-3392 (web) |
Links | |
A contract was signed between TERMIS and the Mary Ann Liebert publisher which designated the journal Tissue Engineering, Parts A, B, and C as the official journal of TERMIS with free on-line access for the membership. [7]
It was agreed that there would be a World Congress every three years, with each Chapter organizing its own conference in the intervening two years.
Each TERMIS chapter has defined awards to recognize outstanding scientists and their contributions within the community.
2016 |
|
2017 |
|
2018 |
|
2021 |
|
2022 |
|
2013 |
|
2014 |
|
2016 |
|
2017 |
|
2019 |
|
2020 |
|
2021 |
|
2022 |
|
2023 |
|
2010 |
|
2011 |
|
2012 |
|
2013 |
|
2014 |
|
2015 |
|
2016 |
|
2017 |
|
2018 |
|
2020 |
|
2021 |
|
2022 |
|
2023 |
|
Fellows of Tissue Engineering and Regenerative Medicine (FTERM) recipients are: [8]
Emeritus
Deceased Fellows
Anthony Atala is an American bioengineer, urologist, and pediatric surgeon. He is the W.H. Boyce professor of urology, the founding director of the Wake Forest Institute for Regenerative Medicine, and the chair of the Department of Urology at Wake Forest School of Medicine in North Carolina. His work focuses on the science of regenerative medicine: "a practice that aims to refurbish diseased or damaged tissue using the body's own healthy cells".
Ali Khademhosseini is an Iranian-born Canadian-American engineer. He is the CEO of the Terasaki Institute, non-profit research organization in Los Angeles, and Omeat Inc., a cultivated-meat startup. Before taking his current CEO roles, he spent one year at Amazon Inc. Prior to that he was the Levi Knight chair and professor at the University of California-Los Angeles where he held a multi-departmental professorship in Bioengineering, Radiology, Chemical, and Biomolecular Engineering as well as the Director of Center for Minimally Invasive Therapeutics (C-MIT). From 2005 to 2017, he was a professor at Harvard Medical School, and the Wyss Institute for Biologically Inspired Engineering.
Cato T. Laurencin FREng SLMH is an American engineer, physician, scientist, innovator and a University Professor of the University of Connecticut.
Clemens A. van Blitterswijk is a Dutch tissue engineer who contributed to the use of biomaterials to heal bone injuries, especially using osteoinductive ceramics. In collaboration with Jan de Boer and others, he has contributed to screening microtextures to study cell-biomaterial interactions, an approach termed materiomics.
Nick Rhodes is a Reader in Tissue Engineering and Regenerative Medicine at the University of Liverpool, in the U.K. Tissue Engineering can be described as the use of engineering techniques, including engineering materials and processes, in order to grow living tissues. Regenerative Medicine can be described as the treatment of defective tissues using the regenerative capacity of the body's healthy tissues. Rhodes describes the discipline as "aiming to repair tissue defects by driving regeneration of healthy tissues using engineered materials and processes."
Linda Gay Griffith is an American biological engineer, and Professor of Biological Engineering and Mechanical Engineering at Massachusetts Institute of Technology, where she also directs the Center for Gynepathology Research.
David James Mooney is Robert P. Pinkas Family Professor of Bioengineering at the Harvard School of Engineering and Applied Sciences. He is also a founding core faculty member at the Wyss Institute for Biologically Inspired Engineering at Harvard University.
Gordana Vunjak-NovakovicFRSC is a Serbian American biomedical engineer and university professor. She is a University Professor at Columbia University, as well as the Mikati Foundation Professor of Biomedical Engineering and Medical Sciences. She also heads the laboratory for Stem Cells and Tissue Engineering at Columbia University. She is part of the faculty at the Irving Comprehensive Cancer Center and the Center for Human Development, both found at Columbia University. She is also an honorary professor at the Faculty of Technology and Metallurgy at the University of Belgrade, an honorary professor at the University of Novi Sad, and an adjunct professor at the Department of Biomedical Engineering at Tufts University.
Buddy Ratner is an American professor of chemical engineering and bioengineering. He is the director of the Research Center for Biomaterials at the University of Washington. He is also the faculty member for the Program for Technology Commercialization at the University of Washington.
Rui Luís Reis is a Portuguese scientist known for his research in tissue engineering, regenerative medicine, biomaterials, biomimetics, stem cells, and biodegradable polymers.
Molly S. Shoichet, is a Canadian science professor, specializing in chemistry, biomaterials and biomedical engineering. She was Ontario's first Chief Scientist. Shoichet is a biomedical engineer known for her work in tissue engineering, and is the only person to be a fellow of the three National Academies in Canada.
Charles Alfred "Chuck" Vacanti is a researcher in tissue engineering and stem cells and the Vandam/Covino Professor of Anesthesiology, Emeritus, at Harvard Medical School. He is a former head of the Department of Anesthesiology at the University of Massachusetts and Brigham and Women’s Hospital, now retired.
Anthony Steven Weiss is an Australian university researcher, company founder and entrepreneur. He is the leading scientist in human tropoelastin research and synthetic human elastin. He holds the McCaughey Chair in Biochemistry, heads the Charles Perkins Centre Node in Tissue Engineering and Regenerative Medicine, and is Professor of Biochemistry and Molecular Biotechnology at the University of Sydney. His discoveries are on human elastic materials that accelerate the healing and repair of arteries, skin and 3D human tissue components. He is a Fellow of the Royal Society of Chemistry. Weiss is on the editorial boards of the American Chemical Society Biomaterials Science and Engineering, Applied Materials Today (Elsevier), Biomaterials, Biomedical Materials, BioNanoScience (Springer) and Tissue Engineering. He is a biotechnology company founder, promoter of national and international technology development, and has received national and international awards, including the Order of Australia.
Alan J. Russell, is Vice President of Biologics for Amgen, one of the world’s leading Biopharmaceutical companies. Until 2020, Alan was the Highmark Distinguished Career Professor and Director of the Disruptive Health Technology Institute at Carnegie Mellon University. From 2013 through spring of 2016 he was also the Chief Innovation Officer, Allegheny Health Network.
Prof. Robert Geoffrey "Geoff" Richards FLSW FBSE FIOR FORS FTERM is the Executive Director Research & Development for the AO Foundation and director of AO Research Institute Davos at the AO Foundation. He is a Fellow of the Learned Society of Wales (FLSW), Fellow of Biomaterial Science and Engineering (FBSE), Fellow of International Orthopaedic Research (FIOR), Fellow of the Orthopaedic Research Society and honorary Fellow Aberystwyth University. He is co-founder and Editor-in-Chief of the eCM Open Access Journal, arguably the first online open access journal in the world.
Patricia Helena Lucas Pranke is a Brazilian stem cell researcher at the Federal University of Rio Grande do Sul. Between 2003 and 2005, Pranke was one of two scientists who helped the Federal Government of Brazil write the National Biosafety Law, regulating research on human embryonic stem cells in Brazil.
Katja Schenke-Layland is the Professor of Medical Technologies and Regenerative Medicine, Institute of Biomedical Engineering, Department for Medical Technologies and Regenerative Medicine at the University of Tübingen. She is the Director of the NMI Natural and Medical Sciences Institute at the University Tübingen in Reutlingen, Study Dean of Medical Technologies at the University of Tübingen, and Founding Director of the Institute of Biomedical Engineering at the Medical Faculty of the University Tübingen. She is also the Founding Director of the 3R Center for In Vitro Models and Alternatives to Animal Testing Tübingen.
Helen Haiyan Lu is a Chinese American biomedical engineer and the Percy K. and Vida L. W. Hudson professor of biomedical engineering at the Columbia University Fu Foundation School of Engineering and Applied Science. Her work focuses on understanding and developing therapies in complex tissue systems, especially the interface between soft tissue and bone.
Melissa F. Grunlan is an American scientist and academic. She is Professor and Holder of the Charles H. and Bettye Barclay Professorship in the Department of Biomedical Engineering at Texas A&M University. She holds courtesy appointments in the Departments of Chemistry and Materials Science & Engineering. Her research focuses on the development of polymeric biomaterials for regenerative engineering and medical devices.
Joseph Vacanti is an American pediatric surgeon and researcher who is the director of the Laboratory of Tissue Engineering and Organ Fabrication at Massachusetts General Hospital. He is the John Homans Professor of Surgery at Harvard Medical School.